XiaodongYangMDMS

Anesthesiology • West Hollywood, CA

Cardiothoracic Anesthesiology, Critical Care Medicine

Mount Sinai/ Cedars Sinai

Join to view full profile

Dr. Yang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Yang's full profile

Already have an account?

Office
8700 Beverly Blvd
West Hollywood, CA 90048
Phone+1 310-423-5841

Fax+1 310-423-0387

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Adult Cardiothoracic Anesthesiology, 2010 - 2011
Icahn School of Medicine at Mount SinaiFellowship, Critical Care Medicine, 2009 - 2010
Johns Hopkins UniversityResidency, Anesthesiology, 2005 - 2009
Flushing Hospital Medical CenterResidency, Internal Medicine, 2002 - 2005
West China University of Medical SciencesClass of 1994

Certifications & Licensure

CA State Medical License 2011 - 2025
NY State Medical License 2010 - 2025
American Board of Anesthesiology Anesthesiology

Publications & Presentations

PubMed

3 citations
Overt Disseminated Intravascular Coagulation with Severe Hypofibrinogenemia During Veno-Venous Extracorporeal Membrane Oxygenation.
Stephen Yang, Brittney Williams, David Kaczorowski, Michael Mazzeffi
The Journal of Extra-Corporeal Technology. 2022-06-01
1 citations
Thrombopoietin, Soluble CD40 Ligand, and Platelet Count During Veno-arterial Extracorporeal Membrane Oxygenation.
Michael A. Mazzeffi, Reney Henderson, Elizabeth K. Powell, Erik Strauss, Brittney Williams
ASAIO Journal. 2021-06-02
1 citations
Utilization of Transverse Abdominis Plexus Block for Treatment of HeartMate II Left Ventricular Assist Device-Associated Pain.
Antonio Hernandez Conte, J. Hajj, Stephen X. Yang, E. Passano, H. Barone
Journal of Cardiothoracic and Vascular Anesthesia. 2017-12-02

Press Mentions

Apexigen Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 15th, 2022
Apexigen Announces Nature Medicine Publication and ASCO Presentation on the Phase 2 PRINCE Trial Showcasing Distinct Biosignatures in Metastatic Pancreatic Cancer Patients Treated with Sotigalimab and/or Nivolumab in Combination with ChemotherapyJune 6th, 2022
Apexigen to Host Key Opinion Leader Webinar on Sotigalimab in Post-Anti-PD-(L)1 MelanomaNovember 9th, 2021
Join now to see all